Literature DB >> 1831560

Behavioural effects of selective dopamine D-1 and D-2 agonists and antagonists in guinea-pigs.

P J Brent1.   

Abstract

This study describes specific behaviours in guinea-pigs after dopamine D-1 and D-2 receptor activation which differed to those described in other rodent species. Intraperitoneal (IP) administration of the dopamine D-2 receptor agonist quinpirole (1.5, 3 and 6 mg/kg) to guinea-pigs dose-dependently initiated locomotor activity and other behaviours including rearing, head-down sniffing, chewing, circling, licking and head/body shaking. Locomotor activity induced by quinpirole (3 mg/kg) was reduced by the D-2 receptor antagonists sulpiride, (100 mg/kg IP) and raclopride (10 mg/kg IP). The dopamine D-1 receptor agonist SKF 38393 (8, 16 and 32 mg/kg IP) produced little or no behavioural effect, nor did the D-1 receptor antagonist SCH 23390 (0.2 and 0.4 mg/kg IP). A 16 mg/kg dose of SKF 38393, given in combination with 3 mg/kg quinpirole, produced responses similar to quinpirole alone, whereas 32 mg kg SKF 38393 combined with quinpirole induced vacuous oral chewing, with attenuation of locomotor activity and circling, but not other behaviours produced by this dose of quinpirole. In contrast to previous studies in rats, the responses to quinpirole (3 mg/kg) were not significantly affected by SCH 23390 (0.2 and 0.4 mg/kg). It is concluded that the guinea-pig may be a useful and interesting species for study of the behavioural effects of D-1 and D-2 agonists and antagonists, as its responses appear to differ from those of other rodent species, but are similar to some responses to D-1 agonists observed in primates.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831560     DOI: 10.1007/bf02244179

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  37 in total

1.  The D1 agonist SKF 38393 inhibits the antiparkinsonian activity of the D2 agonist LY 171555 in the MPTP-treated marmoset.

Authors:  M Nomoto; P Jenner; C D Marsden
Journal:  Neurosci Lett       Date:  1988-11-11       Impact factor: 3.046

2.  Behavioural synergism between the dopamine agonists SKF 38393 and LY 171555 in dopamine-depleted mice: antagonism by sulpiride reveals only stimulant postsynaptic D-2 receptors.

Authors:  M S Starr; B S Starr
Journal:  Pharmacol Biochem Behav       Date:  1989-05       Impact factor: 3.533

3.  Increased plasma catecholamines and locomotor activity induced by centrally administered substance P in guinea-pigs.

Authors:  P J Brent; P A Johnston; L A Chahl
Journal:  Neuropharmacology       Date:  1988-07       Impact factor: 5.250

4.  D-1/D-2 behavioural interactions in the rat involving striatal dopamine D-1 receptors.

Authors:  M S Starr
Journal:  Eur J Pharmacol       Date:  1988-07-14       Impact factor: 4.432

5.  Selective D1 and D2 receptor manipulation in Cebus monkeys: relevance for dystonia and dyskinesia in humans.

Authors:  K Kistrup; J Gerlach
Journal:  Pharmacol Toxicol       Date:  1987-09

Review 6.  Two dopamine receptors: biochemistry, physiology and pharmacology.

Authors:  J C Stoof; J W Kebabian
Journal:  Life Sci       Date:  1984-12-03       Impact factor: 5.037

7.  Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390.

Authors:  A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Selective dopamine D2 receptor reduction enhances a D1-mediated oral dyskinesia in rats.

Authors:  H Rosengarten; J W Schweitzer; A J Friedhoff
Journal:  Life Sci       Date:  1986-07-07       Impact factor: 5.037

9.  Permissive role of D-1 receptor stimulation by endogenous dopamine for the expression of postsynaptic D-2-mediated behavioural responses. Yawning in rats.

Authors:  R Longoni; L Spina; G Di Chiara
Journal:  Eur J Pharmacol       Date:  1987-02-10       Impact factor: 4.432

10.  The D-1 dopamine receptor partial agonist, CY 208-243, exhibits antiparkinsonian activity in the MPTP-treated marmoset.

Authors:  J A Temlett; P N Chong; W H Oertel; P Jenner; C D Marsden
Journal:  Eur J Pharmacol       Date:  1988-11-01       Impact factor: 4.432

View more
  5 in total

Review 1.  Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.

Authors:  Marc A Mergy; Raajaram Gowrishankar; Gwynne L Davis; Tammy N Jessen; Jane Wright; Gregg D Stanwood; Maureen K Hahn; Randy D Blakely
Journal:  Neurochem Int       Date:  2013-12-08       Impact factor: 3.921

2.  Similar behavioural effects of sigma agonists and PCP-like non-competitive NMDA antagonists in guinea-pigs.

Authors:  P J Brent
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Morphine, D-Pen2, D-Pen5 enkephalin and U50,488H differentially affect the locomotor activity and behaviours induced by quinpirole in guinea-pigs.

Authors:  P J Brent; G Bot
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Biphasic locomotor effects of the dopamine D1 agonist SKF 38393 and their attenuation in non-habituated mice.

Authors:  E Tirelli; P Terry
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Differential antagonism of the effects of dopamine D1-receptor agonists on feeding behavior in the rat.

Authors:  P Terry; J L Katz
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.